Current and historical daily PE Ratio for HBM Holdings Ltd (
) from 2021 to Jun 09 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. HBM stock (HBMHF) PE ratio as of Jun 09 2024 is 5.92.
More Details
HBM Holdings Ltd (HBMHF) PE Ratio (TTM) Chart
HBM Holdings Ltd (HBMHF) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 554
- 1
- 2
- 3
- 4
- 5
- 6
- 7
| HBM PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-09 | 16.1 | 2024-04-05 | 16.1 |
| 2024-06-07 | 16.1 | 2024-04-04 | 16.1 |
| 2024-06-06 | 16.1 | 2024-04-03 | 16.1 |
| 2024-06-05 | 16.1 | 2024-04-02 | 16.1 |
| 2024-06-04 | 16.1 | 2024-04-01 | 16.1 |
| 2024-06-03 | 16.1 | 2024-03-28 | 16.1 |
| 2024-05-31 | 16.1 | 2024-03-27 | 16.1 |
| 2024-05-30 | 16.1 | 2024-03-26 | 16.1 |
| 2024-05-29 | 16.1 | 2024-03-25 | 16.1 |
| 2024-05-28 | 16.1 | 2024-03-22 | 16.1 |
| 2024-05-24 | 16.1 | 2024-03-21 | 16.1 |
| 2024-05-23 | 16.1 | 2024-03-20 | 16.1 |
| 2024-05-22 | 16.1 | 2024-03-19 | 16.1 |
| 2024-05-21 | 16.1 | 2024-03-18 | 16.1 |
| 2024-05-20 | 16.1 | 2024-03-15 | 16.1 |
| 2024-05-17 | 16.1 | 2024-03-14 | 16.1 |
| 2024-05-16 | 16.1 | 2024-03-13 | 16.1 |
| 2024-05-15 | 16.1 | 2024-03-12 | 16.1 |
| 2024-05-14 | 16.1 | 2024-03-11 | 16.1 |
| 2024-05-13 | 16.1 | 2024-03-08 | 16.1 |
| 2024-05-10 | 16.1 | 2024-03-07 | 16.1 |
| 2024-05-09 | 16.1 | 2024-03-06 | 16.1 |
| 2024-05-08 | 16.1 | 2024-03-05 | 16.1 |
| 2024-05-07 | 16.1 | 2024-03-04 | 16.1 |
| 2024-05-06 | 16.1 | 2024-03-01 | 16.1 |
| 2024-05-03 | 16.1 | 2024-02-29 | 16.1 |
| 2024-05-02 | 16.1 | 2024-02-28 | 16.1 |
| 2024-05-01 | 16.1 | 2024-02-27 | 16.1 |
| 2024-04-30 | 16.1 | 2024-02-26 | 16.1 |
| 2024-04-29 | 16.1 | 2024-02-23 | 16.1 |
| 2024-04-26 | 16.1 | 2024-02-22 | 16.1 |
| 2024-04-25 | 16.1 | 2024-02-21 | 16.1 |
| 2024-04-24 | 16.1 | 2024-02-20 | 16.1 |
| 2024-04-23 | 16.1 | 2024-02-16 | 16.1 |
| 2024-04-22 | 16.1 | 2024-02-15 | 16.1 |
| 2024-04-19 | 16.1 | 2024-02-14 | 16.1 |
| 2024-04-18 | 16.1 | 2024-02-13 | 16.1 |
| 2024-04-17 | 16.1 | 2024-02-12 | 16.1 |
| 2024-04-16 | 16.1 | 2024-02-09 | 16.1 |
| 2024-04-15 | 16.1 | 2024-02-08 | 16.1 |
| 2024-04-12 | 16.1 | 2024-02-07 | 16.1 |
| 2024-04-11 | 16.1 | 2024-02-06 | 16.1 |
| 2024-04-10 | 16.1 | 2024-02-05 | 16.1 |
| 2024-04-09 | 16.1 | 2024-02-02 | 16.1 |
| 2024-04-08 | 16.1 | 2024-02-01 | 16.1 |
HBM Holdings Ltd (HBMHF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
HBM Holdings Ltd
ISIN : KYG4403H1002
Share Class Description:
HBMHF: Ordinary SharesCompare
Compare
Traded in other countries / regions
02142.Hong Kong6XY.GermanyHBMHF.USA IPO Date
2021-06-10Description
HBM Holdings Ltd is a clinical-stage biopharmaceutical company engaged in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. Its products under development are Batoclimab, for the treatment of a wide spectrum of autoimmune diseases; Tanfanercept, for the treatment of moderate-to-severe dry eye disease (DED); HBM4003; HBM9378, to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus; HBM7008; and others. Its geographical segments are Mainland China, United States, Europe, and others. The majority of the revenue for the firm is generated from the United States.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers